Newsroom

Sorted by: Latest

-

U.S. Food and Drug Administration Approves FoundationOne®Liquid CDx as the First Companion Diagnostic in the U.S. for WILSERDLY (giredestrant) in Combination with Everolimus for ER-Positive, HER2-Negative, ESR1-Mutated Advanced Breast Cancer

BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic (CDx) for WILSERDLY (giredestrant) in combination with everolimus. FoundationOne Liquid CDx is the first FDA-approved companion diagnostic to identify patients who may be eligible for WILSERDLY in combination with everolimus and is...
-

MediaCo Reports Third Quarter Financial Results

NEW YORK--(BUSINESS WIRE)--MediaCo Holding Inc. (Nasdaq: MDIA) reported financial results for the third quarter ended September 30, 2026. Year-to-date Net Revenue was $94.0 million, down $0.7 million, or 1%, from the prior year, driven primarily by a decrease in spot revenue, partially offset by new digital revenue sales. Year-to-date Net Loss was $27.3 million, compared to a Net Loss of $33.9 million from the prior year, primarily due to a decrease in music licensing, rent, utilities, non-cash...
-

AYTU Stock Alert: Halper Sadeh LLC is Investigating Whether Aytu BioPharma, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Aytu BioPharma, Inc. (NASDAQ: AYTU) to Rosemont Pharmaceuticals Holdings, Inc. for $2.70 per share.Halper Sadeh encourages Aytu shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Aytu and its board of directors vio...
-

IQM accompagne les travaux de NVIDIA visant à rendre les ordinateurs quantiques planifiables via Slurm

CHICAGO--(BUSINESS WIRE)--IQM Quantum Computers (Nasdaq : IQMX), leader mondial des ordinateurs quantiques supraconducteurs, a anoncé aujourd’hui, à l'occasion du salon SC26 à Chicago, son soutien à l’initiative de NVIDIA visant à faire des unités de traitement quantique (QPU) une ressource planifiable au sein du gestionnaire de charges de travail du logiciel Slurm, en y intégrant les ordinateurs quantiques d’IQM. NVIDIA, qui s'est engagée à maintenir Slurm comme logiciel open source et indépen...
-

WD to Participate in Upcoming Investor Conferences

SAN JOSE, Calif.--(BUSINESS WIRE)--Western Digital Corporation (Nasdaq: WDC) today announced management participation in the following upcoming investor conferences: Event: UBS Global Technology and AI Conference Date: Tuesday, December 1, 2026, at 11:15 a.m. PT / 2:15 p.m. ET Event: 55th Nasdaq London Investor Conference Date: Tuesday, December 8, 2026, at 7:00 a.m. PT / 10:00 a.m. ET The management presentations will be available as live webcasts, accessible through WD's Investor Relations we...
-

IQM unterstützt die Bemühungen von NVIDIA, Quantencomputer in Slurm planbar zu machen

CHICAGO--(BUSINESS WIRE)--IQM Quantum Computers (Nasdaq: IQMX), ein Weltmarktführer im Bereich supraleitender Quantencomputer, hat heute auf der SC26 in Chicago bekannt gegeben, dass das Unternehmen die Bemühungen von NVIDIA unterstützt, Quantenprozessoreinheiten (QPUs) durch die Integration von IQM-Quantencomputern zu einer planbaren Ressource im Slurm-Workload-Manager zu machen. NVIDIA, dessen erklärtes Ziel es ist, Slurm als Open-Source-Projekt und herstellerneutral verfügbar zu halten, gab...
-

Accord Announces Third Quarter Financial Results and Amendment to its Banking Facility

TORONTO--(BUSINESS WIRE)--Accord Announces Third Quarter Financial Results and Amendment to its Banking Facility...
-

OFS Credit Company Announces Preliminary Estimates of Certain Financial Results for its Fourth Fiscal Quarter 2026

CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (Nasdaq: OCCI, OCCIM, OCCIN) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced preliminary estimates of certain financial results for the fiscal quarter ended October 31, 2026. PRELIMINARY ESTIMATES OF CERTAIN FINANCIAL RESULTS Management’s unaudited estimate of the range of our net asset value per share of our co...
-

Fuze Health Advances Chronic Care Through Its Technology-Led Intelligent Care Platform and Partner Collaboration

SAN FRANCISCO--(BUSINESS WIRE)--Fuze Health advances chronic care through technology-led intelligent care platform and new partner collaborations...
-

Gov. Reynolds Announces U.S. Treasury Approval of 44 Iowa Opportunity Zones

DES MOINES, Iowa--(BUSINESS WIRE)--Today, Governor Kim Reynolds announced that the U.S. Department of the Treasury has approved 44 Iowa census tracts as Qualified Opportunity Zones. The new designations will take effect January 1, 2027, and remain in place for 10 years. Opportunity Zones are economically distressed census tracts submitted by governors and certified by Treasury to encourage long-term private investment. Taxpayers who reinvest eligible capital gains through Qualified Opportunity...